Cargando…
Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study
BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases (PM) is considered to be feasible, safe and to improve survival. AIM: To investigate whether an immune response is activated following HIPEC for PM. METHODS: Six patients were enrolled in this study. Peripheral b...
Autores principales: | Fiorentini, Giammaria, Sarti, Donatella, Patriti, Alberto, Eugeni, Emilio, Guerra, Francesco, Masedu, Francesco, Mackay, Andrew Reay, Guadagni, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450817/ https://www.ncbi.nlm.nih.gov/pubmed/32874953 http://dx.doi.org/10.5306/wjco.v11.i6.397 |
Ejemplares similares
-
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2020) -
Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study
por: Guadagni, Stefano, et al.
Publicado: (2019) -
Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study
por: Fiorentini, Giammaria, et al.
Publicado: (2023) -
Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
por: Fiorentini, Giammaria, et al.
Publicado: (2021) -
Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)